Every year, about 50,000 women in the US are diagnosed with ductal carcinoma in situ, or DCIS, where the cells that line milk ...

Some early breast cancer patients can safely avoid specific surgeries, according to two studies exploring ways to lessen ...

Every year, over 20 million people globally are diagnosed with cancer and close to 9.5 million people will reportedly succumb ...

A recent advancement that’s making an impact on patients’ lives is CAR-T cell therapy. With CAR-T, providers take these cells from a patient’s blood and change them, so they are able to recognize a ...

The novel link between nutrition and cell identity offers a new explanation for exhausted T cell identity and in turn, offers a multitude of new targets for future therapeutics that could keep T cells ...

The decision between scrambled eggs or an apple for breakfast probably won't make or break your day. However, for your cells, ...

Stay updated on promising new treatments for Diffuse Large B-cell Lymphoma and B-cell acute lymphoblastic leukemia in this ...

The relationship the immune system and stromal cells in pancreatic cancer can have a significant impact on patients' survival ...

Researchers used lab-grown organoids created from tumors of individuals with glioblastoma (GBM) to accurately model a patient's response to CAR T cell therapy in real time. The organoid's response to ...

Evaxion’s AI-Immunology™ platform allows for the design of precision cancer vaccines targeting non-conventional ERV tumor antigens shared across ...

TuHURA Biosciences, Inc. (Nasdaq: HURA) is a Phase 3 registration-stage immuno-oncology company developing novel technologies ...